Search - tctmd.com

Displaying 281 - 295 of 295

Sort: Relevancy | Date

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Conference News ACC 2012

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

March 25, 2012

News Daily News

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

March 07, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

Statin Users Have Better Outcomes After PCI for Stable CAD

L.A. McKeown

July 08, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

CME

Advertisement

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

ESC Congress 2011: Drugs, Devices Work Together

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

Statin Users Have Better Outcomes After PCI for Stable CAD

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Changing Course with Anticoagulation in Secondary Prevention of CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content